Therapy Areas: Inflammatory Diseases
11 September 2019 - Biopharmaceutical company Soligenix Inc (Nasdaq: SNGX) disclosed on Wednesday that Jonathan Guarino has been appointed as the company's senior vice president and chief financi...
5 September 2019 - - The US Food and Drug Administration has granted Fast Track designation to nangibotide development program for the treatment of septic shock, French biotechnology company Inotrem S...
3 September 2019 - Biotechnology company Inotrem SA revealed on Tuesday the receipt of the US Food and Drug Administration (FDA) Fast Track designation for the nangibotide development programme for th...
3 September 2019 - Swiss biopharmaceutical company Strekin AG reported on Monday that it has received CHF2.82m under its Series A financing round with private investors.The company said the funds will...
2 September 2019 - United Kingdom-based AstraZeneca has achieved its primary endpoint in the phase III Tulip two trial of new medicine anifrolumab for systemic lupus erythematosus, it is reported toda...